| pembrolizumab based treatment | pembrolizumab alone | pembrolizumab based treatment |
| pembrolizumab alone | pembrolizumab (10mg/kg) | pembrolizumab (10mg/kg) 2 weeks | pembrolizumab (2mg/kg) | pembrolizumab plus SoC |
Comparator:
vs ipilimumab alone; vs Standard of Care (SoC); vs placebo plus SoC; vs placebo;
Risk of bias:
low;
some concerns;
high;
NA;